Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,241 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06919562Recruiting
Better stent placement using imaging and newer scaffolds
This trial tests if using advanced imaging (like OCT or IVUS) to guide placement of a newer type of stent (bioresorbable scaffold) can reduce future stent problems. It is for people with stable coronary artery disease who need a stent in a main heart artery.
DordrechtAges 18 years+ - NCT06916286Recruiting
Surgical drain securement and patient quality of life
This trial studies if different ways of securing surgical drains after surgery can improve your comfort and reduce complications. You may join if you are having a procedure that will require a surgical drain.
Winston-Salem, North CarolinaAges 18 years+ - NCT06914219Recruiting
Eating disorder screening after weight loss surgery
This study tests a program to screen for and treat eating disorders in people who have had weight loss surgery. It aims to find and help those struggling with eating issues after surgery.
Halifax, Nova ScotiaAges 19 years+ - NCT06919744Recruiting
Stenting for intracranial hypertension: early treatment study
This trial tests whether placing a small tube (stent) in a narrowed brain vein can help people with newly diagnosed intracranial hypertension (high pressure in the head) that causes vision problems. It is for those who have not yet taken standard medication and have specific vein narrowing seen on MRI.
MontpellierAges 18 years+ - NCT06917313RecruitingPhase 2
Fezolinetant for hot flashes in women with breast cancer on hormone therapy
This trial tests a drug called fezolinetant to see if it reduces hot flashes in women with HR+ breast cancer who are on hormone therapy (like tamoxifen or aromatase inhibitors). You need to be postmenopausal and having at least 7 moderate to severe hot flashes a day.
New Haven, ConnecticutAges 18 years+ - NCT06916390RecruitingPhase 4
Testing guselkumab with antibiotics for chronic pouchitis
This study tests whether adding a medication called guselkumab to antibiotics can help people with chronic or recurring pouchitis, a condition that causes inflammation in the J-pouch after ulcerative colitis surgery. Participants will take antibiotics for the first 4 weeks and guselkumab as an injection over the course of the trial.
Leuven, Vlaams-BrabantAges 18 years+ - NCT06917001RecruitingPhase 2
Testing Resomelagon for dengue fever
This trial tests whether a new medicine called Resomelagon can safely treat dengue fever. It looks at how well the medicine works and if it helps you recover faster.
Belo Horizonte, Minas GeraisAges 18–65 - NCT06917209Recruiting
Therapy for dissociative disorders trial
This trial tests a type of talk therapy called dissociation-focused cognitive behavior therapy for people with dissociative disorders (like feeling detached from yourself or having multiple identities). It aims to see if this therapy can help reduce symptoms.
AngersAges 18 years+ - NCT06919419Recruiting
PrEP study for people in Dallas County Jail
This study tests a program to help people in jail get PrEP, a daily pill that prevents HIV. It aims to see if the program works well and is easy to use.
Dallas, TexasAges 18 years+ - NCT06914999RecruitingEarly Phase 1
Comparing a new scan to standard scan during head and neck cancer radiation
This trial is testing whether a newer type of PET/CT scan (F-18 NaF) can better detect blood vessel problems caused by radiation therapy than the standard scan (F-18 FDG) in people with head and neck cancer. If successful, it could lead to better ways to prevent and manage these complications.
Atlanta, GeorgiaAges 18 years+ - NCT06917781Recruiting
Prostate cancer blood test vs. PSMA-PET scan study
This study is checking how well a blood test (liquid biopsy) can find prostate cancer and compare it to a special PET scan (PSMA-PET). If you qualify, you might help improve how we track prostate cancer without needing more invasive biopsies.
ToulouseAges 18 years+ - NCT06915792RecruitingPhase 4
Postpartum blood pressure medication and stopping study
This trial compares two blood pressure medicines, nifedipine and labetalol, to see which works better for new mothers with high blood pressure after giving birth. It aims to find the best way to safely stop medicine as blood pressure improves.
Los Angeles, CaliforniaAges 18–64 - NCT06918392Recruiting
Testing a questionnaire for teens with pectus excavatum
This study tests a questionnaire about living with pectus excavatum (sunken chest). If you are a teen (12-18) scheduled for the Nuss procedure, you and your parent can help by filling out the questionnaire to see if it works well.
HeerlenAges 12–18 - NCT05481502Recruiting
Study looks at immune markers after cell therapy
This study collects immune and tumor-related samples to learn what predicts response to adoptive cell therapy (a treatment using immune cells). If you (or your child) are eligible, you may help researchers understand who benefits and why.
Villejuif, Val De MarneAges 2 years+ - NCT06885385RecruitingPhase 2
Study of JS207 with or without JS015 and chemo for colorectal cancer
This trial tests a new drug combination (JS207 with or without JS015) along with chemotherapy for people with advanced colorectal cancer that has not spread to other parts of the body. It aims to see if the treatment is safe and helps shrink tumors.
Beijing, Beijing MunicipalityAges 18–75 - NCT06906042Recruiting
Imaging study of heart and liver health in volunteers
This trial uses advanced imaging (like MRI) to look at the heart and liver in people who are generally healthy. It aims to find early signs of disease and understand what normal, healthy imaging looks like.
ParisAges 20 years+ - NCT06904846Enrolling by invitation
Testing a new continuous glucose monitor for 60 days
This study tests a new continuous glucose monitor (CGM) called iCan o3 that you wear on your abdomen for 60 days. It helps track your blood sugar levels continuously, so you and your doctor can see patterns and make better decisions about your diabetes care.
AntwerpAges 18–75 - NCT06909877RecruitingPhase 1/Phase 2
Study of HH2853 for relapsed or refractory peripheral T-cell lymphoma
This trial tests an experimental drug, HH2853, for people with certain types of T-cell lymphoma that have come back or not responded to prior treatments. It aims to see if the drug is safe and effective.
Chengdu, ChengduAges 18–75 - NCT06907615RecruitingPhase 2
Study of HLX43 for advanced non-small cell lung cancer
This trial tests a new drug, HLX43, for people with advanced non-small cell lung cancer that has not responded to standard treatments. It aims to see if HLX43 can help shrink or control the cancer.
Houston, TexasAges 18 years+ - NCT06905873RecruitingPhase 1
Testing FB102 for non-segmental vitiligo
This study tests a new medicine called FB102 for people with non-segmental vitiligo. It aims to see if the drug is safe and helps restore skin color.
Darlinghurst, New South WalesAges 18–75 - NCT06902402Recruiting
Support drink for people having cancer treatment
This study tests whether a special drink, Supportan, is safe and helpful for people currently undergoing cancer treatments like chemotherapy, radiation, immunotherapy, or targeted therapy. The drink is designed to support nutrition during treatment.
Keelung, TaiwanAges 18 years+ - NCT06904807RecruitingPhase 1
Safety study of LIFE-001 in healthy volunteers
This trial tests a new drug called LIFE-001 in healthy volunteers to check its safety and how the body handles it. It is for people without significant health issues.
Bayswater, VictoriaAges 18–65 - NCT06909214RecruitingPhase 4
Study of efgartigimod for new-onset generalized myasthenia gravis
This study tests a new treatment called efgartigimod for people who have been recently diagnosed with generalized myasthenia gravis (gMG). It aims to see if this medicine can help manage symptoms like muscle weakness.
La Jolla, CaliforniaAges 18 years+ - NCT04050956Recruiting
Study of heart attack patients soon after symptoms begin
This study follows people who have had a heart attack very recently (within 48 hours) to evaluate care and outcomes. You may be invited if your diagnosis fits a typical heart-attack pattern and you can consent.
ParisAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,241 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.